IBDEI23V ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35713,0)
 ;;=M32.11^^134^1730^9
 ;;^UTILITY(U,$J,358.3,35713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35713,1,3,0)
 ;;=3^Endocarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,35713,1,4,0)
 ;;=4^M32.11
 ;;^UTILITY(U,$J,358.3,35713,2)
 ;;=^5011754
 ;;^UTILITY(U,$J,358.3,35714,0)
 ;;=J67.0^^134^1730^10
 ;;^UTILITY(U,$J,358.3,35714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35714,1,3,0)
 ;;=3^Farmer's Lung
 ;;^UTILITY(U,$J,358.3,35714,1,4,0)
 ;;=4^J67.0
 ;;^UTILITY(U,$J,358.3,35714,2)
 ;;=^44962
 ;;^UTILITY(U,$J,358.3,35715,0)
 ;;=M32.14^^134^1730^11
 ;;^UTILITY(U,$J,358.3,35715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35715,1,3,0)
 ;;=3^Glomerular Disease in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,35715,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,35715,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,35716,0)
 ;;=J67.9^^134^1730^12
 ;;^UTILITY(U,$J,358.3,35716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35716,1,3,0)
 ;;=3^Hypersensitivity Pneumonitis d/t Unspec Organic Dust
 ;;^UTILITY(U,$J,358.3,35716,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,35716,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,35717,0)
 ;;=J84.17^^134^1730^14
 ;;^UTILITY(U,$J,358.3,35717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35717,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,35717,1,4,0)
 ;;=4^J84.17
 ;;^UTILITY(U,$J,358.3,35717,2)
 ;;=^5008301
 ;;^UTILITY(U,$J,358.3,35718,0)
 ;;=J84.113^^134^1730^15
 ;;^UTILITY(U,$J,358.3,35718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35718,1,3,0)
 ;;=3^Idiopathic Non-Specific Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,35718,1,4,0)
 ;;=4^J84.113
 ;;^UTILITY(U,$J,358.3,35718,2)
 ;;=^340535
 ;;^UTILITY(U,$J,358.3,35719,0)
 ;;=J84.112^^134^1730^16
 ;;^UTILITY(U,$J,358.3,35719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35719,1,3,0)
 ;;=3^Idiopathic Pulmonary Fibrosis
 ;;^UTILITY(U,$J,358.3,35719,1,4,0)
 ;;=4^J84.112
 ;;^UTILITY(U,$J,358.3,35719,2)
 ;;=^340534
 ;;^UTILITY(U,$J,358.3,35720,0)
 ;;=J84.111^^134^1730^13
 ;;^UTILITY(U,$J,358.3,35720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35720,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,35720,1,4,0)
 ;;=4^J84.111
 ;;^UTILITY(U,$J,358.3,35720,2)
 ;;=^340610
 ;;^UTILITY(U,$J,358.3,35721,0)
 ;;=J84.9^^134^1730^17
 ;;^UTILITY(U,$J,358.3,35721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35721,1,3,0)
 ;;=3^Interstitial Pulmonary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35721,1,4,0)
 ;;=4^J84.9
 ;;^UTILITY(U,$J,358.3,35721,2)
 ;;=^5008304
 ;;^UTILITY(U,$J,358.3,35722,0)
 ;;=M32.13^^134^1730^19
 ;;^UTILITY(U,$J,358.3,35722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35722,1,3,0)
 ;;=3^Lung Involvement in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,35722,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,35722,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,35723,0)
 ;;=J84.2^^134^1730^20
 ;;^UTILITY(U,$J,358.3,35723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35723,1,3,0)
 ;;=3^Lymphoid Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,35723,1,4,0)
 ;;=4^J84.2
 ;;^UTILITY(U,$J,358.3,35723,2)
 ;;=^5008302
 ;;^UTILITY(U,$J,358.3,35724,0)
 ;;=D86.82^^134^1730^21
 ;;^UTILITY(U,$J,358.3,35724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35724,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,35724,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,35724,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,35725,0)
 ;;=M32.8^^134^1730^60
 ;;^UTILITY(U,$J,358.3,35725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35725,1,3,0)
 ;;=3^Systemic Lupus Erythematosus NEC
